Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2014 Jan 30;2014(1):CD006832.
doi: 10.1002/14651858.CD006832.pub3.

Interventions for preventing critical illness polyneuropathy and critical illness myopathy

Greet Hermans  1 , Bernard De Jonghe, Frans Bruyninckx, Greet Van den Berghe
Affiliations
Meta-Analysis

Interventions for preventing critical illness polyneuropathy and critical illness myopathy

Greet Hermans et al. Cochrane Database Syst Rev. .

Abstract

Background: Critical illness polyneuropathy or myopathy (CIP/CIM) is a frequent complication in the intensive care unit (ICU) and is associated with prolonged mechanical ventilation, longer ICU stay and increased mortality. This is an interim update of a review first published in 2009 (Hermans 2009). It has been updated to October 2011, with further potentially eligible studies from a December 2013 search characterised as awaiting assessment.

Objectives: To systematically review the evidence from RCTs concerning the ability of any intervention to reduce the incidence of CIP or CIM in critically ill individuals.

Search methods: On 4 October 2011, we searched the Cochrane Neuromuscular Disease Group Specialized Register, CENTRAL, MEDLINE, and EMBASE. We checked the bibliographies of identified trials and contacted trial authors and experts in the field. We carried out an additional search of these databases on 6 December 2013 to identify recent studies.

Selection criteria: All randomised controlled trials (RCTs), examining the effect of any intervention on the incidence of CIP/CIM in people admitted to adult medical or surgical ICUs. The primary outcome was the incidence of CIP/CIM in ICU, based on electrophysiological or clinical examination. Secondary outcomes included duration of mechanical ventilation, duration of ICU stay, death at 30 and 180 days after ICU admission and serious adverse events from the treatment regimens.

Data collection and analysis: Two authors independently extracted the data and assessed the risk of bias in included studies.

Main results: We identified five trials that met our inclusion criteria. Two trials compared intensive insulin therapy (IIT) to conventional insulin therapy (CIT). IIT significantly reduced CIP/CIM in the screened (n = 825; risk ratio (RR) 0.65, 95% confidence interval (CI) 0.55 to 0.77) and total (n = 2748; RR 0.70, 95% CI 0.60 to 0.82) population randomised. IIT reduced duration of mechanical ventilation, ICU stay and 180-day mortality, but not 30-day mortality compared with CIT. Hypoglycaemia increased with IIT but did not cause early deaths.One trial compared corticosteroids with placebo (n = 180). The trial found no effect of treatment on CIP/CIM (RR 1.27, 95% CI 0.77 to 2.08), 180-day mortality, new infections, glycaemia at day seven, or episodes of pneumonia, but did show a reduction of new shock events.In the fourth trial, early physical therapy reduced CIP/CIM in 82/104 evaluable participants in ICU (RR 0.62. 95% CI 0.39 to 0.96). Statistical significance was lost when we performed a full intention-to-treat analysis (RR 0.81, 95% CI 0.60 to 1.08). Duration of mechanical ventilation but not ICU stay was significantly shorter in the intervention group. Hospital mortality was not affected but 30- and 180-day mortality results were not available. No adverse effects were noticed.The last trial found a reduced incidence of CIP/CIM in 52 evaluable participants out of a total of 140 who were randomised to electrical muscle stimulation (EMS) versus no stimulation (RR 0.32, 95% CI 0.10 to 1.01). These data were prone to bias due to imbalances between treatment groups in this subgroup of participants. After we imputed missing data and performed an intention-to-treat analysis, there was still no significant effect (RR 0.94, 95% CI 0.78 to 1.15). The investigators found no effect on duration of mechanical ventilation and noted no difference in ICU mortality, but did not report 30- and 180-day mortality.We updated the searches in December 2013 and identified nine potentially eligible studies that will be assessed for inclusion in the next update of the review.

Authors' conclusions: There is moderate quality evidence from two large trials that intensive insulin therapy reduces CIP/CIM, and high quality evidence that it reduces duration of mechanical ventilation, ICU stay and 180-day mortality, at the expense of hypoglycaemia. Consequences and prevention of hypoglycaemia need further study. There is moderate quality evidence which suggests no effect of corticosteroids on CIP/CIM and high quality evidence that steroids do not affect secondary outcomes, except for fewer new shock episodes. Moderate quality evidence suggests a potential benefit of early rehabilitation on CIP/CIM which is accompanied by a shorter duration of mechanical ventilation but without an effect on ICU stay. Very low quality evidence suggests no effect of EMS, although data are prone to bias. Strict diagnostic criteria for CIP/CIM are urgently needed for research purposes. Large RCTs need to be conducted to further explore the role of early rehabilitation and EMS and to develop new preventive strategies.

PubMed Disclaimer

Conflict of interest statement

Greet Hermans and Greet Van den Berghe have been involved in trials included in the review.

Frans Bruyninckx and Bernard De Jonghe have no known conflicts of interest.

Figures

1
1
Presumed pathophysiological mechanisms and their interactions involved in the development of CIP/CIM. Dark shaded area indicates events taking place in the nerves, light shaded area indicates events taking place in the muscle. (Additional abbreviations: ROS, reactive oxygen species; SR, sarcoplasmic reticulum).
2
2
Risk of bias summary: review authors' judgements about each risk of bias item for each included study. Red (‐) = high risk of bias; green (+) = low risk of bias; yellow (?) = unclear risk of bias (not shown).
3
3
Forest plot of comparison: 1 Intensive insulin therapy (IIT) versus conventional insulin therapy (CIT), outcome: 1.1 Occurrence of CIP/CIM.
4
4
Forest plot of comparison: 2 Corticosteroids versus placebo, outcome: 2.1 Occurrence of CIP/CIM.
5
5
Forest plot of comparison: 6 EarIy physical therapy versus control, outcome: 6.1 Occurence of CIP/CIM.
6
6
Forest plot of comparison: 4 Elecrical magnetic stimulation versus control, outcome: 4.1 Occurrence of CIP/CIM.
See this image and copyright information in PMC

Update of

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

References to studies included in this review

Hermans 2007 {published and unpublished data}
    1. Hermans G, Wilmer A, Meersseman W, Milants I, Wouters PJ, Bobbaers H, et al. Impact of intensive insulin therapy on neuromuscular complications and ventilator‐dependency in MICU. American Journal of Respiratory Critical Care Medicine 2007;175(5):480‐9. [PUBMED: 17138955] - PubMed
Routsi 2010 {published data only}
    1. Routsi C, Gerovasili V, Vasileiadis I, Karatzanos E, Pitsolis T, Tripodaki E, et al. Electrical muscle stimulation prevents critical illness polyneuromyopathy: a randomized parallel intervention trial. Critical Care (London, England) 2010;14(2):R74. [PUBMED: 20426834] - PMC - PubMed
Schweickert 2009 {published and unpublished data}
    1. Schweickert WD, Pohlman MC, Pohlman AS, Nigos C, Pawlik AJ, Esbrook CL, et al. Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial. Lancet 2009;373(9678):1874‐82. [PUBMED: 19446324] - PMC - PubMed
Steinberg 2006 {published data only (unpublished sought but not used)}
    1. Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R, et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. New England Journal of Medicine 2006;354(16):1671‐84. [PUBMED: 16625008] - PubMed
Van den Berghe 2005 {published and unpublished data}
    1. Berghe G, Schoonheydt K, Becx P, Bruyninckx F, Wouters PJ. Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology 2005;64(8):1348‐53. [PUBMED: 15851721] - PubMed

References to studies excluded from this review

Berard 2000 {published data only}
    1. Bérard MP, Zazzo JF, Condat P, Vasson MP, Cynober L. Total parenteral nutrition enriched with arginine and glutamate generates glutamine and limits protein catabolism in surgical patients hospitalized in intensive care units. Critical Care Medicine 2000;28(11):3637‐44. [PUBMED: 11098966] - PubMed
Bouletreau 1985 {published data only}
    1. Bouletreau P, Patricot MC, Saudin F, Guiraud M, Mathian B. Effects of intermittent electrical stimulations on muscle catabolism intensive care patients. JPEN. Journal of Parenteral and Enteral Nutrition 1987;11(6):552‐5. [PUBMED: 3501482] - PubMed
Brunello 2010 {published data only}
    1. Brunello AG, Haenggi M, Wigger O, Porta F, Takala J, Jakob SM. Usefulness of a clinical diagnosis of ICU‐acquired paresis to predict outcome in patients with SIRS and acute respiratory failure. Intensive Care Medicine 2010;36(1):66‐74. [PUBMED: 19760204] - PubMed
Burtin 2009 {published and unpublished data}
    1. Burtin C, Clerckx B, Robbeets C, Ferdinande P, Langer D, Troosters T, et al. Early exercise in critically ill patients enhances short‐term functional recovery. Critical Care Medicine 2009;37(9):2499‐505. [PUBMED: 19623052] - PubMed
Caruso 2005 {published and unpublished data}
    1. Caruso P, Denari SD, Ruiz SA, Bernal KG, Manfrin GM, Friedrich C, et al. Inspiratory muscle training is ineffective in mechanically ventilated critically ill patients. Clinics (Sao Paulo, Brazil) 2005;60(6):479‐84. [PUBMED: 16358138] - PubMed
Chen 2011 {published data only}
    1. Chen F, Wang J, Jiang Y. Influence of different routes of nutrition on the respiratory muscle strength and outcome of elderly patients in respiratory intensive care unit. Chinese Journal of Clinical Nutrition 2011;19(1):7‐11.
Chiang 2006 {published data only}
    1. Chiang LL, Wang LY, Wu CP, Wu HD, Wu YT. Effects of physical training on functional status in patients with prolonged mechanical ventilation. Physical Therapy 2006;86(9):1271‐81. [PUBMED: 16959675] - PubMed
Fläring 2003 {published data only}
    1. Fläring UB, Rooyackers OE, Wernerman J, Hammarqvist F. Glutamine attenuates post‐traumatic glutathione depletion in human muscle. Clinical Science 2003;104(3):275‐82. [PUBMED: 12605586] - PubMed
Gamrin 2000 {published data only}
    1. Gamrin L, Essén P, Hultman E, McNurlan MA, Garlick PJ, Wernerman J. Protein‐sparing effect in skeletal muscle of growth hormone treatment in critically ill patients. Annals of Surgery 2000;231(4):577‐86. [PUBMED: 10749620] - PMC - PubMed
Gerovasili 2009a {published data only}
    1. Gerovasili V, Tripodaki E, Karatzanos E, Pitsolis T, Markaki V, Zervakis D, et al. Short‐term systemic effect of electrical muscle stimulation in critically ill patients. Chest 2009;136(5):1249‐56. [PUBMED: 19710290] - PubMed
Gerovasili 2009b {published data only}
    1. Gerovasili V, Stefanidis K, Vitzilaios K, Karatzanos E, Politis P, Koroneos A, et al. Electrical muscle stimulation preserves the muscle mass of critically ill patients: a randomized study. Critical Care (London, England) 2009;13(5):R161. [PUBMED: 19814793] - PMC - PubMed
Gruther 2010 {published data only}
    1. Gruther W, Kainberger F, Fialka‐Moser V, Paternostro‐Sluga T, Quittan M, Spiss C, et al. Effects of neuromuscular electrical stimulation on muscle layer thickness of knee extensor muscles in intensive care unit patients: a pilot study. Journal of Rehabilitation Medicine 2010;42(6):593‐7. [PUBMED: 20549166] - PubMed
Hsieh 2006 {published data only}
    1. Hsieh LC, Chien SL, Huang MS, Tseng HF, Chang CK. Anti‐inflammatory and anticatabolic effects of short‐term beta‐hydroxy‐beta‐methylbutyrate supplementation on chronic obstructive pulmonary disease patients in intensive care unit. Asia Pacific Journal of Clinical Nutrition 2006;15(4):544‐50. [PUBMED: 17077073] - PubMed
Huang 2006 {published data only}
    1. Huang CJ, Lin HC. Association between adrenal insufficiency and ventilator weaning. American Journal of Respiratory and Critical Care Medicine 2006;173(3):276‐80. [PUBMED: 16272449] - PubMed
Johnson 1993 {published data only (unpublished sought but not used)}
    1. Johnson D, Gallagher C, Cavanaugh M, Yip R, Mayers I. The lack of effect of routine magnesium administration on respiratory function in mechanically ventilated patients. Chest 1993;104(2):536‐41. [PUBMED: 8339645] - PubMed
Karatzanos 2012 {published data only}
    1. Karatzanos E, Gerovasili V, Zervakis D, Tripodaki ES, Apostolou K, Vasileiadis I, et al. Electrical muscle stimulation: an effective form of exercise and early mobilization to preserve muscle strength in critically ill patients. Critical Care Research and Practice 2012;2012:432752. [PUBMED: 22545212] - PMC - PubMed
Knox 1996 {published data only}
    1. Knox JB, Wilmore DW, Demling RH, Sarraf P, Santos AA. Use of growth hormone for postoperative respiratory failure. American Journal of Surgery 1996;171(6):576‐80. [PUBMED: 8678203] - PubMed
Kuhls 2007 {published data only}
    1. Kuhls DA, Rathmacher JA, Musngi MD, Frisch DA, Nielson J, Barber A, et al. Beta‐hydroxy‐beta‐methylbutyrate supplementation in critically ill trauma patients. Journal of Trauma 2007;62(1):125‐31. [PUBMED: 17215743] - PubMed
Martin 2011 {published and unpublished data}
    1. Martin AD, Smith BK, Davenport PD, Harman E, Gonzalez‐Rothi RJ, Baz M, et al. Inspiratory muscle strength training improves weaning outcome in failure to wean patients: a randomized trial. Critical Care (London, England) 2011;15(2):R84. [PUBMED: 21385346] - PMC - PubMed
Menadue 2010 {published data only}
    1. Menadue C, Alison JA, Piper AJ, Flunt D, Ellis ER. Bilevel ventilation during exercise in acute on chronic respiratory failure: a preliminary study. Respiratory Medicine 2010;104(2):219‐27. [PUBMED: 19804963] - PubMed
Miao 2005 {published data only}
    1. Miao LJ, Wang J, Liu H, Cheng Z. Role of enteral nutrition combined with parenteral nutrition in supporting mechanical ventilation of patients with chronic obstructive pulmonary disease accompanied by respiratory failure. Chinese Journal of Clinical Rehabilitation 2005;9(31):27‐9.
Mohr 1997 {published data only}
    1. Mohr M, Englisch L, Roth A, Burchardi H, Zielmann S. Effects of early treatment with immunoglobulin on critical illness polyneuropathy following multiple organ failure and gram‐negative sepsis. Intensive Care Medicine 1997;23(11):1144‐9. [PUBMED: 9434920] - PubMed
Morris 2008 {published data only}
    1. Morris PE, Goad A, Thompson C, Taylor K, Harry B, Passmore L, et al. Early intensive care unit mobility therapy in the treatment of acute respiratory failure. Critical Care Medicine 2008;36(8):2238‐43. [PUBMED: 18596631] - PubMed
Nava 1998 {published data only}
    1. Nava S. Rehabilitation of patients admitted to a respiratory intensive care unit. Archives of Physical Medicine and Rehabilitation 1998;79(7):849‐54. [PUBMED: 9685104] - PubMed
Paddon‐Jones 2005 {published data only}
    1. Paddon‐Jones D, Wolfe RR, Ferrando AA. Amino acid supplementation for reversing bed rest and steroid myopathies. Journal of Nutrition 2005;135(7):1809‐12S. [PUBMED: 15987870] - PubMed
Pichard 1996 {published data only (unpublished sought but not used)}
    1. Pichard C, Kyle U, Chevrolet JC, Jolliet P, Slosman D, Mensi N. Lack of effects of recombinant growth hormone on muscle function in patients requiring prolonged mechanical ventilation: a prospective, randomized, controlled study. Critical Care Medicine 1996;24(3):403‐13. [PUBMED: 8625627] - PubMed
Porta 2005 {published data only}
    1. Porta R, Vitacca M, Gilè LS, Clini E, Bianchi L, Zanotti E, et al. Supported arm training in patients recently weaned from mechanical ventilation. Chest 2005;128(4):2511‐20. [PUBMED: 16236917] - PubMed
Rodriguez 2012 {published and unpublished data}
    1. Rodriguez PO, Setten M, Maskin LP, Bonelli I, Vidomlansky SR, Attie S, et al. Muscle weakness in septic patients requiring mechanical ventilation: protective effect of transcutaneous neuromuscular electrical stimulation. Journal of Critical Care 2012;27(3):319 e1‐8. [PUBMED: 21715139] - PubMed
Routsi 2009 {published data only}
    1. Routsi C, Gerovasili V, Zevakis D, Karatzanos E, Papadopoulos E, Pitsolis T, et al. Electrical muscle stimulation prevents critical illness polyneuromyopathy in ICU patients. Intensive Care Medicine. Conference: 22nd Annual Congress of the European Society of Intensive Care Medicine, ESICM Vienna, Austria 2009;35:s133.
Salisbury 2010 {published data only}
    1. Salisbury LG, Merriweather JL, Walsh TS. Rehabilitation after critical illness: could a ward‐based generic rehabilitation assistant promote recovery?. Nursing in Critical Care 2010;15(2):57‐65. [PUBMED: 20236432] - PubMed
Sevette 2005 {published data only}
    1. Sevette A, Smith RC, Aslani A, Kee AJ, Hansen R, Barratt SM, et al. Does growth hormone allow more efficient nitrogen sparing in postoperative patients requiring parental nutrition? A double‐blind placebo‐controlled randomised trial. Clinical Nutrition 2005;24(6):943‐55. [PUBMED: 16083996] - PubMed
Takala 1999a {published and unpublished data}
    1. Takala J, Ruokonen E, Webster NR, Nielsen MS, Zandstra DF, Vundelinckx G, et al. Increased mortality associated with growth hormone treatment in critically ill adults. New England Journal of Medicine 1999;341(11):785‐92. [PUBMED: 10477776] - PubMed
Takala 1999b {published and unpublished data}
    1. Takala J, Ruokonen E, Webster NR, Nielsen MS, Zandstra DF, Vundelinckx G, et al. Increased mortality associated with growth hormone treatment in critically ill adults. New England Journal of Medicine 1999;341(11):785‐92. [PUBMED: 10477776] - PubMed
Tjäder 2004 {published data only}
    1. Tjäder I, Rooyackers O, Forsberg AM, Vesali RF, Garlick PJ, Wernerman J. Effects on skeletal muscle of intravenous glutamine supplementation to ICU patients. Intensive Care Medicine 2004;30(2):266‐75. [PUBMED: 14722645] - PubMed
Toledo 2007 {published data only}
    1. Toledo A, Borghi‐Silva A, Sampaio LM, Ribeiro KP, Baldissera V, Costa D. The impact of noninvasive ventilation during the physical training in patients with moderate‐to‐severe chronic obstructive pulmonary disease (COPD). Clinics (Sao Paulo, Brazil) 2007;62(2):113‐20. [PUBMED: 17505694] - PubMed
Vivodtzev 2006 {published data only}
    1. Vivodtzev I, Pépin JL, Vottero G, Mayer V, Porsin B, Lévy P, et al. Improvement in quadriceps strength and dyspnea in daily tasks after 1 month of electrical stimulation in severely deconditioned and malnourished COPD. Chest 2006;129(6):1540‐8. [PUBMED: 16778272] - PubMed
Watters 1997 {published data only (unpublished sought but not used)}
    1. Watters JM, Kirkpatrick SM, Norris SB, Sharmji FM, Wells GA. Immediate postoperative enteral feeding results in impaired respiratory mechanics and decreased mobility. Annals of Surgery 1997;226(3):369‐77. [PUBMED: 9339943] - PMC - PubMed
Zanotti 2003 {published data only (unpublished sought but not used)}
    1. Zanotti E, Felicetti G, Maini M, Fracchia C. Peripheral muscle strength training in bed‐bound patients with COPD receiving mechanical ventilation: effect of electrical stimulation. Chest 2003;124(1):292‐6. [PUBMED: 12853536] - PubMed
Ziegler 1990 {published data only}
    1. Ziegler TR, Young LS, Ferrari‐Baliviera E, Demling RH, Wilmore DW. Use of human growth hormone combined with nutritional support in a critical care unit. JPEN. Journal of Parenteral and Enteral Nutrition 1990;14(6):574‐81. [PUBMED: 2273531] - PubMed

References to studies awaiting assessment

Abokhabar 2012 {published data only}
    1. Abokhabar H, Abouelela A, Abdelkarim I. Effect of electrical muscle stimulation in prevention of ICU acquired muscle weakness and facilitation of weaning from mechanical ventilation. Intensive Care Medicine. 2012; Vol. 38:S132.
Alia 2011 {published data only}
    1. Alía I, Cal MA, Esteban A, Abella A, Ferrer R, Molina FJ, et al. Efficacy of corticosteroid therapy in patients with an acute exacerbation of chronic obstructive pulmonary disease receiving ventilatory support. Archives of Internal Medicine 2011;171(21):1939‐46. [PUBMED: 22123804] - PubMed
Brunner 2013 {published data only}
    1. Brunner R, Rinner W, Haberler C, Kitzberger R, Sycha T, Herkner H, et al. Early treatment with IgM‐enriched intravenous immunoglobulin does not mitigate critical illness polyneuropathy and/or myopathy in patients with multiple organ failure and SIRS/sepsis: a prospective, randomized, placebo‐controlled, double‐blinded trial. Critical Care (London, England) 2013;17(5):R213. [PUBMED: 24088271] - PMC - PubMed
Devost 2011 {published data only}
    1. Devost A‐A, Boilard G, Vovodtzev, Saey D, Mainguy V, Maltais F, et al. Efficiency of neuromuscular electrical stimulation to prevent ICU‐acquired weakness in mechanically ventilated patients. Intensive Care Medicine. 2011:S13.
Files 2013 {published data only}
    1. Files D, Morris P, Shrestha S, Dhar S, Young M, Hauser J, et al. Randomized, controlled pilot study of early rehabilitation strategies in acute respiratory failure. Critical Care 2013;17(Suppl 2):P540.
Gerovasili 2011 {published data only}
    1. Gerovasili V, Karatzanos L, Zervakis D, Dimopoulos S, Tripodaki E‐S, Pitsolis T, et al. Electrical muscle simulation is an effective form of excercise and early rehabilitation in ICU patients. American Journal of Respiratory and Critical Care Medicine. 2011; Vol. 183:A3740.
Hermans 2013 {published data only}
    1. Hermans G, Casaer MP, Clerckx B, Güiza F, Vanhullebusch T, Derde S, et al. Effect of tolerating macronutrient deficit on the development of intensive‐care unit acquired weakness: a subanalysis of the EPaNIC trial. The Lancet Respiratory Medicine 2013;1(8):621‐9. - PubMed
Mikaeili 2012 {published data only}
    1. Mikaeili H, Yazdchi M, Barazandeh F, Ansarin K. Euglycemic state reduces the incidence of critical illness polyneuropathy and duration of ventilator dependency in medical intensive care unit. Bratislavské Lekárske Listy 2012;113(10):616‐9. [PUBMED: 23094903] - PubMed
Paternostro‐Sluga 2012 {published data only}
    1. Paternostro‐Sluga T, Hiesmayr M, Janda D, Senekowitsch S. Early neuromuscular electrical stimulation for intensive care unit patients: effect on muscle strength and urinary nitrogen excretion. The Journal of Injury, Function, and Rehabilitation 2012;4(10 Suppl):S310.

References to ongoing studies

Kho 2012 {published data only}
    1. Kho ME, Truong AD, Brower RG, Palmer JB, Fan E, Zanni JM, et al. Neuromuscular electrical stimulation for intensive care unit‐acquired weakness: protocol and methodological implications for a randomized, sham‐controlled, phase II trial. Physical Therapy 2012;92(12):1564‐79. [PUBMED: 22421734] - PMC - PubMed
Parry 2012 {published data only}
    1. Parry SM, Berney S, Koopman R, Bryant A, El‐Ansary D, Puthucheary Z, et al. Early rehabilitation in critical care (eRiCC): functional electrical stimulation with cycling protocol for a randomised controlled trial. BMJ Open 2012;2(5):e001891. [PUBMED: 22983782] - PMC - PubMed

Additional references

Atkins 2004
    1. Atkins D, Eccles M, Flottorp S, Guyatt GH, Henry D, Hill S, et al. GRADE Working Group. Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group. BMC Health Services Research 2004;4(1):38. [PUBMED: 15615589] - PMC - PubMed
Bednarík 2005
    1. Bednarík J, Vondracek P, Dusek L, Moravcova E, Cundrle I. Risk factors for critical illness polyneuromyopathy. Journal of Neurology 2005;252(3):343‐51. [PUBMED: 15791390] - PubMed
Berek 1997a
    1. Berek K, Margreiter J, Willeit J, Berek A, Schmutzhard E, Mutz N. Critical illness polyneuropathy‐‐only due to parenteral nutrition?. Intensive care medicine 1997; Vol. 23, issue 8:923‐4. [PUBMED: 9310818] - PubMed
Berger 1996
    1. Berger JR, Pall L, Hall CD, Simpson DM, Berry PS, Dudley R. Oxandrolone in AIDS‐wasting myopathy. AIDS 1996;10(14):1657‐62. [PUBMED: 8970686] - PubMed
Bollaert 1998
    1. Bollaert PE, Charpentier C, Levy B, Debouverie M, Audibert G, Larcan A. Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Critical Care Medicine 1998;26(4):645‐50. [PUBMED: 9559600] - PubMed
Bolton 1984
    1. Bolton CF, Gilbert JJ, Hahn AF, Sibbald WJ. Polyneuropathy in critically ill patients. Journal of Neurology, Neurosurgery & Psychiatry 1984;47(11):1223‐31. [PUBMED: 6094735] - PMC - PubMed
Bolton 1986
    1. Bolton CF, Laverty DA, Brown JD, Witt NJ, Hahn AF, Sibbald WJ. Critically ill polyneuropathy: electrophysiological studies and differentiation from Guillain‐Barré syndrome. Journal of Neurology, Neurosurgery & Psychiatry 1986;49(5):563‐73. [PUBMED: 3011996] - PMC - PubMed
Bolton 2005
    1. Bolton CF. Neuromuscular manifestations of critical illness. Muscle & Nerve 2005;32(2):140‐63. [PUBMED: 15825186] - PubMed
Boyer 2006
    1. Boyer A, Chadda K, Salah A, Annane D. Glucocorticoid treatment in patients with septic shock: effects on vasopressor use and mortality. International Journal of Clinical Pharmacology and Therapeutics 2006;44(7):309‐18. [PUBMED: 16961159] - PubMed
Brealey 2002
    1. Brealey D, Brand M, Hargreaves I, Heales S, Land J, Smolenski R, et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 2002;360(9328):219‐23. [PUBMED: 12133657] - PubMed
Briegel 1999
    1. Briegel J, Forst H, Haller M, Schelling G, Kilger E, Kuprat G, et al. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double‐blind, single‐center study. Critical Care Medicine 1999;27(4):723‐32. [PUBMED: 10321661] - PubMed
Burnham 2005
    1. Burnham EL, Moss M, Ziegler TR. Myopathies in critical illness: characterization and nutritional aspects. The Journal of Nutrition 2005;135(7):1818S‐23S. [PUBMED: 15987872] - PubMed
Chalwa 1999
    1. Chalwa K, Kupfer Y, Goldmann I, Tessler S. Hydrocortisone reverses refractory shock. Critical Care Medicine 1999;27(1S):33A.
Coakley 1998
    1. Coakley JH, Nagendran K, Yarwood GD, Honavar M, Hinds CJ. Patterns of neurophysiological abnormality in prolonged critical illness. Intensive Care Medicine 1998;24(8):801‐7. [PUBMED: 9757924] - PubMed
De Jonghe 1998
    1. Jonghe B, Cook D, Sharshar T, Lefaucheur JP, Carlet J, Outin H. Acquired neuromuscular disorders in critically ill patients: a systematic review. Groupe de Reflexion et d'Etude sur les Neuromyopathies En Reanimation. Intensive Care Medicine 1998;24(12):1242‐50. [PUBMED: 9885875] - PMC - PubMed
De Jonghe 2002
    1. Jonghe B, Sharshar T, Lefaucheur JP, Authier FJ, Durand‐Zaleski I, Boussarsar M, et al. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA 2002;288(22):2859‐67. [PUBMED: 12472328] - PubMed
de Letter 2001
    1. Letter MA, Schmitz PI, Visser LH, Verheul FA, Schellens RL, Op de Coul DA, et al. Risk factors for the development of polyneuropathy and myopathy in critically ill patients. Critical Care Medicine 2001;29(12):2281‐6. [PUBMED: 11801825] - PubMed
Deeks 2011
    1. Deeks JJ, Higgins JPT, Altman DG (editors). Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). Available from www.cochrane‐handbook.org. Higgins JPT, Green S, 2011.
Deley 2005
    1. Deley G, Kervio G, Verges B, Hannequin A, Petitdant MF, Salmi‐Belmihoub S, et al. Comparison of low‐frequency electrical myostimulation and conventional aerobic exercise training in patients with chronic heart failure. European Journal of Cardiovascular Prevention & Rehabilitation 2005;12(3):226‐33. [PUBMED: 15942420] - PubMed
Finfer 2009
    1. NICE‐SUGAR Study Investigators, Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, et al. Intensive versus conventional glucose control in critically ill patients. New England Journal of Medicine 2009;360(13):1283‐97. [PUBMED: 19318384] - PubMed
Garnacho‐Montero 2001
    1. Garnacho‐Montero J, Madrazo‐Osuna J, Garcia‐Garmendia JL, Ortiz‐Leyba C, Jimenez‐Jimenez FJ, Barrero‐Almodovar A, et al. Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients. Intensive Care Medicine 2001;27(8):1288‐96. [PUBMED: 11511941] - PubMed
Gore 1991
    1. Gore DC, Honeycutt D, Jahoor F, Wolfe RR, Herndon DN. Effect of exogenous growth hormone on whole‐body and isolated‐limb protein kinetics in burned patients. Archives of Surgery 1991;126(1):38‐43. [PUBMED: 1898697] - PubMed
Hammarqvist 1997
    1. Hammarqvist F, Luo JL, Cotgeave IA, Andersson K, Wernerman J. Skeletal muscle glutathione is depleted in critically ill patients. Critical Care Medicine 1997;25(1):78‐84. [PUBMED: 8989180] - PubMed
Herridge 2003
    1. Herridge MS, Cheung AM, Tansey CM, Matte‐Martyn A, Diaz‐Granados N, Al Saidi F, et al. One‐year outcomes in survivors of the acute respiratory distress syndrome. New England Journal of Medicine 2003;348(8):683‐93. [PUBMED: 12594312] - PubMed
Herridge 2011
    1. Herridge MS, Tansey CM, Matté A, Tomlinson G, Diaz‐Granados N, Cooper A, et al. Functional disability 5 years after acute respiratory distress syndrome. New England Journal of Medicine 2011;364(14):1293‐304. [PUBMED: 21470008] - PubMed
Higgins 2011a
    1. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Higgins 2011b
    1. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Jeevanandam 1995
    1. Jeevanandam M, Ali MR, Holaday NJ, Petersen SR. Adjuvant recombinant human growth hormone normalizes plasma amino acids in parenterally fed trauma patients. JPEN. Journal of Parenteral and Enteral Nutrition 1995;19(2):137‐44. [PUBMED: 7609279] - PubMed
Kleyweg 1991
    1. Kleyweg RP, Meché FG, Schmitz PI. Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain‐Barré syndrome. Muscle & Nerve 1991;14(11):1103‐9. [PUBMED: 1745285] - PubMed
Langouche 2005
    1. Langouche L, Vanhorebeek I, Vlasselaers D, Vander PS, Wouters PJ, Skogstrand K, et al. Intensive insulin therapy protects the endothelium of critically ill patients. Journal of Clinical Investigation 2005;115(8):2277‐86. [PUBMED: 16075063] - PMC - PubMed
Meduri 1998
    1. Meduri GU, Headley AS, Golden E, Carson SJ, Umberger RA, Kelso T, et al. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA 1998;280(2):159‐65. [PUBMED: 9669790] - PubMed
Mendenhall 1993
    1. Mendenhall CL, Moritz TE, Roselle GA, Morgan TR, Nemchausky BA, Tamburro CH, et al. A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis: results of a Department of Veterans Affairs cooperative study. Hepatology 1993;17(4):564‐76. [PUBMED: 8477961] - PubMed
Michelsen 1982
    1. Michelsen CB, Askanazi J, Kinney JM, Gump FE, Elwyn DH. Effect of an anabolic steroid on nitrogen balance and amino acid patterns after total hip replacement. Journal of Trauma 1982;22(5):410‐3. [PUBMED: 6804639] - PubMed
Nanas 2008
    1. Nanas S, Kritikos K, Angelopoulos E, Siafaka A, Tsikriki S, Poriazi M, et al. Predisposing factors for critical illness polyneuromyopathy in a multidisciplinary intensive care unit. Acta Neurologica Scandinavica 2008;118(3):175‐81. [PUBMED: 18355395] - PubMed
Nuhr 2004
    1. Nuhr MJ, Pette D, Berger R, Quittan M, Crevenna R, Huelsman M, et al. Beneficial effects of chronic low‐frequency stimulation of thigh muscles in patients with advanced chronic heart failure. European Heart Journal 2004;25(2):136‐43. [PUBMED: 14720530] - PubMed
Pandit 2006
    1. Pandit L, Agrawal A. Neuromuscular disorders in critical illness. Clinical Neurology and Neurosurgery 2006;108(7):621‐7. [PUBMED: 16730883] - PubMed
Papazian 2010
    1. Papazian L, Forel JM, Gacouin A, Penot‐Ragon C, Perrin G, Loundou A, et al. ACURASYS Study Investigators. Neuromuscular blockers in early acute respiratory distress syndrome. New England Journal of Medicine 2010;363(12):1107‐16. [PUBMED: 20843245] - PubMed
Pape 1991
    1. Pape GS, Friedman M, Underwood LE, Clemmons DR. The effect of growth hormone on weight gain and pulmonary function in patients with chronic obstructive lung disease. Chest 1991;99(6):1495‐500. [PUBMED: 2036835 ] - PubMed
Ponting 1988
    1. Ponting GA, Halliday D, Teale JD, Sim AJ. Postoperative positive nitrogen balance with intravenous hyponutrition and growth hormone. Lancet 1988;1(8583):438‐40. [PUBMED: 2893867] - PubMed
RevMan 2012 [Computer program]
    1. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
Rowe 2001
    1. Rowe BH, Spooner C, Ducharme FM, Bretzlaff JA, Bota GW. Early emergency department treatment of acute asthma with systemic corticosteroids. Cochrane Database of Systematic Reviews 2001, Issue 1. [DOI: 10.1002/14651858.CD002178; PUBMED: 11279756] - DOI - PubMed
Schols 1995
    1. Schols AM, Soeters PB, Mostert R, Pluymers RJ, Wouters EF. Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo‐controlled randomized trial. American Journal of Respiratory and Critical Care Medicine 1995;152(4 Pt 1):1268‐74. [PUBMED: 7551381] - PubMed
Sharshar 2010
    1. Sharshar T, Bastuji‐Garin S, Jonghe B, Stevens RD, Polito A, Maxime V, et al. Hormonal status and ICU‐acquired paresis in critically ill patients. Intensive Care Medicine 2010;36(8):1318‐26. [PUBMED: 20333354] - PubMed
Stevens 2007
    1. Stevens RD, Dowdy DW, Michaels RK, Mendez‐Tellez PA, Pronovost PJ, Needham DM. Neuromuscular dysfunction acquired in critical illness: a systematic review. Intensive Care Medicine 2007;33(11):1876‐91. [PUBMED: 17639340] - PubMed
Tennilä 2000
    1. Tennilä A, Salmi T, Pettilä V, Roine RO, Varpula T, Takkunen O. Early signs of critical illness polyneuropathy in ICU patients with systemic inflammatory response syndrome or sepsis. Intensive Care Medicine 2000;26(9):1360‐3. [PUBMED: 11089765] - PubMed
Van den Berghe 2001
    1. Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in the critically ill patients. New England Journal of Medicine 2001;345(19):1359‐67. [PUBMED: 11794168] - PubMed
Van den Berghe 2004
    1. Berghe G. How does blood glucose control with insulin save lives in intensive care?. Journal of Clinical Investigation 2004;114(9):1187‐95. [PUBMED: 15520847] - PMC - PubMed
Van den Berghe 2006a
    1. Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, et al. Intensive insulin therapy in the medical ICU. New England Journal of Medicine 2006;354(5):449‐61. [PUBMED: 16452557] - PubMed
Van den Berghe 2006b
    1. Berghe G, Wilmer A, Milants I, Wouters PJ, Bouckaert B, Bruyninckx F, et al. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes 2006;55(11):3151‐9. [PUBMED: 17065355] - PubMed
Voerman 1992
    1. Voerman HJ, Schijndel RJ, Groeneveld AB, Boer H, Nauta JP, Veen EA, et al. Effects of recombinant human growth hormone in patients with severe sepsis. Annals of Surgery 1992;216(6):648‐55. [PUBMED: 1466618] - PMC - PubMed
Voerman 1995
    1. Voerman BJ, Strack van Schijndel RJ, Groeneveld AB, Boer H, Nauta JP, Thijs LG. Effects of human growth hormone in critically ill nonseptic patients: results from a prospective, randomized, placebo‐controlled trial. Critical Care Medicine 1995;23(4):665‐73. [PUBMED: 7712756] - PubMed
Waldhausen 1997
    1. Waldhausen E, Mingers B, Lippers P, Keser G. Critical illness polyneuropathy due to parenteral nutrition. Intensive Care Medicine 1997; Vol. 23, issue 8:922‐3. [PUBMED: 9310817] - PubMed
Weber‐Carstens 2010
    1. Weber‐Carstens S, Deja M, Koch S, Spranger J, Bubser F, Wernecke KD, et al. Risk factors in critical illness myopathy during the early course of critical illness: a prospective observational study. Critical Care (London, England) 2010;14(3):R119. [PUBMED: 20565863] - PMC - PubMed
Weitzel 2009
    1. Weitzel LR, Sandoval PA, Mayles WJ, Wischmeyer PE. Performance‐enhancing sports supplements: role in critical care. Critical Care Medicine 2009;37(10 Suppl):S400‐9. [PUBMED: 20046127] - PubMed
Witt 1991
    1. Witt NJ, Zochodne DW, Bolton CF, Grand'Maison F, Wells G, Young GB, et al. Peripheral nerve function in sepsis and multiple organ failure. Chest 1991;99(1):176‐84. [PUBMED: 1845860] - PubMed

References to other published versions of this review

Hermans 2007
    1. Hermans G, Jonghe B, Bruyninckx F, Berghe G. Interventions for preventing critical illness polyneuropathy and critical illness myopathy (Protocol). Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews 2007, Issue 4. [DOI: 10.1002/14651858.CD006832] - DOI - PubMed
Hermans 2009
    1. Hermans G, Jonghe B, Bruyninckx F, Berghe G. Interventions for preventing critical illness polyneuropathy and critical illness myopathy. Cochrane Database of Systematic Reviews 2009, Issue 1. [DOI: 10.1002/14651858.CD006832.pub2; PUBMED: 19160304] - DOI - PubMed

MeSH terms